According to the complaint, which was filed in federal court in Connecticut on Thursday, the defendants coordinated with their competitors at industry trade shows, customer conferences and other events, as well as through direct email, phone and text message communications. The 20 states also allege that the drug companies knew their conduct was illegal and avoided communicating with one another in writing.